Showing results (1411-1420 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|August 7, 2025
Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosisLinda Ye, Ian Dick, Bruce W Robinson, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2025
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cellsSina Taheri Baghmisheh, Chung-Hsing Chen, Yu-Min Yeh, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Manganese potentiation of autologous anti-Meth A tumor vaccines. A developmental studyD L McCollester
Cancer Immunology, Immunotherapy : CII|August 14, 2021
Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expressionHiroshi Takumida, Hidehito Horinouchi, Ken Masuda, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2021
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcomaJennifer A Lenz, Charles-Antoine Assenmacher, Victoria Costa, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2021
Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapyMohamed Labib Salem, Samar Salman, Ibrahim O Barnawi
Cancer Immunology, Immunotherapy : CII|May 12, 2021
Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patientsYuchao Fei, Yifan Cao, Yun Gu, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2020
Metabolomic profiling of tumor-infiltrating macrophages during tumor growthNaoki Umemura, Masahiro Sugimoto, Yusuke Kitoh, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2020
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumorsRobin Fröbom, Erik Berglund, David Berglund, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2021
SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cellsMeriem Bahri, Sareetha Kailayangiri, Sarah Vermeulen, et al.
Pageof 651